61 related articles for article (PubMed ID: 23428429)
1. Gata3 antagonizes cancer progression in Pten-deficient prostates.
Nguyen AH; Tremblay M; Haigh K; Koumakpayi IH; Paquet M; Pandolfi PP; Mes-Masson AM; Saad F; Haigh JJ; Bouchard M
Hum Mol Genet; 2013 Jun; 22(12):2400-10. PubMed ID: 23428429
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer.
De Velasco MA; Kura Y; Yoshikawa K; Nishio K; Davies BR; Uemura H
Oncotarget; 2016 Mar; 7(13):15959-76. PubMed ID: 26910118
[TBL] [Abstract][Full Text] [Related]
3. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.
Seshacharyulu P; Rachagani S; Muniyan S; Siddiqui JA; Cruz E; Sharma S; Krishnan R; Killips BJ; Sheinin Y; Lele SM; Smith LM; Talmon GA; Ponnusamy MP; Datta K; Batra SK
Oncogene; 2019 Jun; 38(26):5265-5280. PubMed ID: 30914801
[TBL] [Abstract][Full Text] [Related]
4. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal negative feedback regulation of ATF6α and PTEN promotes prostate cancer progression.
Feng T; Zhao R; Zhang H; Sun F; Hu J; Wang M; Qi M; Liu L; Gao L; Xiao Y; Zhen J; Chen W; Wang L; Han B
Cell Mol Life Sci; 2023 Sep; 80(10):292. PubMed ID: 37715829
[TBL] [Abstract][Full Text] [Related]
6. The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.
Turnham DJ; Bullock N; Dass MS; Staffurth JN; Pearson HB
Cells; 2020 Oct; 9(11):. PubMed ID: 33105713
[TBL] [Abstract][Full Text] [Related]
7. Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer.
Zhao D; Cai L; Lu X; Liang X; Li J; Chen P; Ittmann M; Shang X; Jiang S; Li H; Meng C; Flores I; Song JH; Horner JW; Lan Z; Wu CJ; Li J; Chang Q; Chen KC; Wang G; Deng P; Spring DJ; Wang YA; DePinho RA
Cancer Discov; 2020 Sep; 10(9):1374-1387. PubMed ID: 32385075
[TBL] [Abstract][Full Text] [Related]
8. Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer.
Zhang M; Ceyhan Y; Mei S; Hirz T; Sykes DB; Agoulnik IU
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001678
[TBL] [Abstract][Full Text] [Related]
9. Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.
Zhang B; Liu M; Mai F; Li X; Wang W; Huang Q; Du X; Ding W; Li Y; Barwick B; Ni J; Osunkoya A; Chen Y; Zhou W; Xia S; Dong JT
J Clin Invest; 2024 May; ():. PubMed ID: 38781024
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.
De Velasco MA; Uemura H
Adv Urol; 2012; 2012():419348. PubMed ID: 22454635
[TBL] [Abstract][Full Text] [Related]
11. Lineage Specification from Prostate Progenitor Cells Requires Gata3-Dependent Mitotic Spindle Orientation.
Shafer MER; Nguyen AHT; Tremblay M; Viala S; Béland M; Bertos NR; Park M; Bouchard M
Stem Cell Reports; 2017 Apr; 8(4):1018-1031. PubMed ID: 28285879
[TBL] [Abstract][Full Text] [Related]
12. Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence.
Popov H; Ghenev P; Stoyanov GS
Cureus; 2023 Sep; 15(9):e44998. PubMed ID: 37829946
[TBL] [Abstract][Full Text] [Related]
13. ZMYM2 is essential for methylation of germline genes and active transposons in embryonic development.
Graham-Paquin AL; Saini D; Sirois J; Hossain I; Katz MS; Zhuang QK; Kwon SY; Yamanaka Y; Bourque G; Bouchard M; Pastor WA
Nucleic Acids Res; 2023 Aug; 51(14):7314-7329. PubMed ID: 37395395
[TBL] [Abstract][Full Text] [Related]
14. Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines.
Boeschen M; Le Duc D; Stiller M; von Laffert M; Schöneberg T; Horn S
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5539-5545. PubMed ID: 36472769
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Models for Prostate Cancer Research.
Adamiecki R; Hryniewicz-Jankowska A; Ortiz MA; Li X; Porter-Hansen BA; Nsouli I; Bratslavsky G; Kotula L
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358740
[TBL] [Abstract][Full Text] [Related]
16. PTEN Protein Phosphatase Activity Is Not Required for Tumour Suppression in the Mouse Prostate.
Wise HM; Harris A; Kriplani N; Schofield A; Caldwell H; Arends MJ; Overton IM; Leslie NR
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291720
[TBL] [Abstract][Full Text] [Related]
17. Precision intervention for prostate cancer: Re-evaluating who is at risk.
Papachristodoulou A; Abate-Shen C
Cancer Lett; 2022 Jul; 538():215709. PubMed ID: 35490919
[TBL] [Abstract][Full Text] [Related]
18. GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Bianco G; Coto-Llerena M; Gallon J; Kancherla V; Taha-Mehlitz S; Marinucci M; Konantz M; Srivatsa S; Montazeri H; Panebianco F; Tirunagaru VG; De Menna M; Paradiso V; Ercan C; Dahmani A; Montaudon E; Beerenwinkel N; Kruithof-de Julio M; Terracciano LM; Lengerke C; Jeselsohn RM; Doebele RC; Bidard FC; Marangoni E; Ng CKY; Piscuoglio S
Commun Biol; 2022 Apr; 5(1):373. PubMed ID: 35440675
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.
Sereesongsaeng N; McDowell SH; Burrows JF; Scott CJ; Burden RE
Breast Cancer Res; 2020 Dec; 22(1):139. PubMed ID: 33298139
[TBL] [Abstract][Full Text] [Related]
20. Increased phagocytosis in the presence of enhanced M2-like macrophage responses correlates with increased primary and latent HSV-1 infection.
Jaggi U; Yang M; Matundan HH; Hirose S; Shah PK; Sharifi BG; Ghiasi H
PLoS Pathog; 2020 Oct; 16(10):e1008971. PubMed ID: 33031415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
